QualityStocksNewsBreaks Archives - Page 165 of 1424

FridayMar 15, 2024 3:16 pm

QualityStocksNewsBreaks – GEMXX Corp. (GEMZ) Poised for Opportunity in Burgeoning Indian Market

GEMXX (OTC: GEMZ), a leading mine-to-market company focused on mining and producing jewelry out of gold and ammolite, recently provided a positive outlook covering India’s burgeoning markets for colored gemstones and jewelry. “In the press release, GEMXX highlighted recent industry forecasts, which anticipate that the jewelry market in India will surge by US$21.54 billion between 2023 and 2027, representing an impressive CAGR of 5.54%. This growth, GEMXX holds, is positioning India as a key player in the global jewelry arena. The company also singled out the colored gemstones market in India, which analysts expect to reach US$707.8 million in 2024…

FridayMar 15, 2024 2:01 pm

QualityStocksNewsBreaks – Astiva Health Addressing Challenges of Traditional Caregiving Structures

Astiva Health is a leading healthcare provider that specializes in delivering personalized and comprehensive solutions to diverse communities. The company is leading the charge in creating essential healthcare solutions tailored for the expanding aging Asian American community, which is undergoing a considerable demographic shift, with a growing segment of the population requiring more support. “The company is proactively meeting the unique needs of this group by providing healthcare services that are culturally sensitive and honor the diverse traditions and values across Asian cultures… Astiva Health’s commitment to culturally sensitive care acknowledges the importance of traditional values such as filial piety…

FridayMar 15, 2024 1:08 pm

QualityStocksNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Filling Gap in Therapeutic Antibody Treatment Space

Sigyn Therapeutics (OTCQB: SIGY), a development-stage medical technology company, is currently focused on the development of four therapeutic candidates to address clearly defined limitations in global health. These include the ImmunePrep(TM) platform to enhance the performance of immunotherapeutic antibodies to treat cancer, ChemoPrep(TM) to enhance the targeted delivery of chemotherapy, ChemoPure(TM) to reduce the toxicity of chemotherapy, and Sigyn Therapy(TM) to address pathogen-associated conditions that are beyond the reach of drugs. “Though highly valued, [immunotherapeutic antibodies to treat cancer] are limited by poor delivery to cancer cell targets and as a result, most patients do not respond to therapy. Inhibiting…

FridayMar 15, 2024 12:46 pm

QualityStocksNewsBreaks – Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Well Positioned to Capitalize on World’s Ongoing Energy Transition

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF), a Canadian natural resource exploration and development company, is keen on targeting high-grade nickel sulfide developments for use in the rapidly growing electric vehicle market. “Led by a management team boasting over 100 years of combined mining and exploration experience and having raised gross proceeds of approximately C$7.5 million over the past six months to fund its incremental exploration work, Fathom Nickel has set its sights on developing two key nickel projects – the Albert Lake and Gochager Lake projects,” a recent article reads. “With total EV sales anticipated to swell from…

FridayMar 15, 2024 11:51 am

QualityStocksNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Is Expanding Global Reach with Innovative Products

SenesTech (NASDAQ: SNES) is dramatically improving pest management technicians’ toolboxes with its patent-pending Evolve(R) soft bait birth control product for rodents, which joins the liquid ContraPest(TM) product in providing non-lethal solutions to reducing rodent populations. “The patent-pending Evolve(TM) soft bait has a sausage-like appearance and poses little or no risk to human health or the environment – a significant advantage over poisons used to kill rats. SenesTech’s products are the first, and still the only, such rat contraceptives registered with the U.S. Environmental Protection Agency (‘EPA’) that target both male and female rats… The company recommends using its Birth Control…

FridayMar 15, 2024 11:33 am

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Publication of Peer-Reviewed Research for Investigational Drug CNM-Au8(R)

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, today announced the publication of peer-reviewed research, titled “Protein Corona Composition of Gold Nanocrystals.” The publication appeared in the journal ACS Pharmacology & Translational Science and fully characterized the proteins from human blood plasma that form the protein corona of the gold nanocrystals of CNM-Au8(R), Clene’s investigational drug in development for the treatment of neurodegenerative diseases. “The protein corona of CNM-Au8 gold nanocrystals, tailored for brain delivery…

ThursdayMar 14, 2024 3:45 pm

QualityStocksNewsBreaks – Software Effective Solutions Corp. (SFWJ) Moving to Become World’s Premier Resource for High-Quality Pharmaceutical Products

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana) has established five companies focused on pharmaceutical cannabis production, managing processes for plant-to-patient operations, and irrigation and greenhouse technology. “A global infrastructure and holding company in the cannabis industry, MedCana is on a mission to become the world’s premier resource for pharmaceutical cannabis products,” reads a recent article that discusses the burgeoning global medical marijuana market and the increasing trend of cannabis decriminalization around the world. “With this backdrop of growing awareness and acceptance of medical cannabis, MedCana is well positioned to become an industry leader. The company has assembled a team of…

ThursdayMar 14, 2024 3:02 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Names Experienced Corporate Finance Exec as New CFO

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has appointed a new chief financial officer. The company announced that, effective immediately, Nelson Cabatuan, CPA, will serve in the position, which also entails being a member of Lexaria’s executive leadership team. Cabatuan brings more than 15 years of corporate finance and operations experience in the life sciences industry. Most recently, he served as senior vice president of finance and operations at Rain Oncology Inc., a late-stage precision oncology biotech company. In that position, he was pivotal in building and leading the company’s financial organization, resulting in significant growth…

ThursdayMar 14, 2024 2:37 pm

QualityStocksNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Enrolls First Patients in Key Study Assessing Proprietary AIMIGo(TM) System

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has begun enrolling the first patients in its VALID-ECG pivotal study. According to the announcement, the first patients were enrolled at Atlanta Heart Specialists, a top cardiology physician practice in Atlanta, Georgia. HeartBeam anticipates the VALID-ECG study will form the basis of its planned FDA 510(k) submission. The study is designed to evaluate the performance of a 12-lead ECG synthesized from the credit-card-sized HeartBeam AIMIGo(TM) system compared to a standard hospital-based 12-lead ECG; the study will use both quantitative and qualitative methodologies…

ThursdayMar 14, 2024 2:21 pm

QualityStocksNewsBreaks – Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Announces 508% Increase in 2023 PDP Reserve Valuation

Prospera (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) today announced a 508% increase to its proven developed producing (“PDP”) reserve value of 27MM$, reflecting the success of the company’s 2023 development program. In addition, Prospera’s proven plus probable (“2P”) reserve value increased by over 60MM$ to a total of 133MM$ – largely driven by the undeveloped reserve value increase from 58MM$ to $98MM$. InSite Petroleum Consultants Ltd. independently assessed PEI’s Dec. 31, 2023, year-end reserves in accordance with COGEH standards. Using a combination of vertical and horizontal wells, primarily in core assets located in Southwest and West-Central Saskatchewan (>42,000 acres), the…

Site Search

Company Search

Category: QualityStocksNewsBreaks